The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model

Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study

(2014) Wim van den Brink et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month Studies

(2013) W. van den Brink et al.   ALCOHOL AND ALCOHOLISM

Naturalistic Disease Management Study of Patients with Alcohol Dependence in the Primary Care Setting in the United Kingdom (STREAM)

(2013) F. Coste et al.   VALUE IN HEALTH

Quality of life among alcohol-dependent patients: How satisfactory are the available instruments? A systematic review

(2012) A. Luquiens et al.   DRUG AND ALCOHOL DEPENDENCE

Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union

(2012) J. Rehm et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Stephen S Lim et al.   LANCET

Model Transparency and Validation

(2012) David M. Eddy et al.   MEDICAL DECISION MAKING

Model Parameter Estimation and Uncertainty Analysis

(2012) Andrew H. Briggs et al.   MEDICAL DECISION MAKING

Epidemiology and alcohol policy in Europe

(2011) Jürgen Rehm et al.   ADDICTION

Indicators of alcohol consumption and attributable harm for monitoring and surveillance in European Union countries

(2011) Jürgen Rehm et al.   ADDICTION

κ-opioid receptors are implicated in the increased potency of intra-accumbens nalmefene in ethanol-dependent rats

(2011) Kathryn A. Nealey et al.   NEUROPHARMACOLOGY

The relation between different dimensions of alcohol consumption and burden of disease: an overview

(2010) Jürgen Rehm et al.   ADDICTION

Initial Preference for Drinking Goal in the Treatment of Alcohol Problems: I. Baseline Differences Between Abstinence and Non-Abstinence Groups

(2010) N. Heather et al.   ALCOHOL AND ALCOHOLISM

Estimated effect of alcohol pricing policies on health and health economic outcomes in England: an epidemiological model

(2010) Robin C Purshouse et al.   LANCET

Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders

(2009) Jürgen Rehm et al.   LANCET

Determination of Lifetime Injury Mortality Risk in Canada in 2002 by Drinking Amount per Occasion and Number of Occasions

(2008) B. Taylor et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY